| RS376626935 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Polyps |
| RS376626985 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram-like syndrome |
| RS376627126 |
MARVELD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 49, Autosomal recessive nonsyndromic hearing loss 49 |
| RS376627489 |
NIN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376628082 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS376628499 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Krabbe disease due to saposin A deficiency, Combined PSAP deficiency |
| RS376628500 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS376629999 |
IL10RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 28, Inborn genetic diseases |
| RS376630030 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 1, 3M syndrome 1 |
| RS376630127 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376630194 |
F11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor XI deficiency disease, Plasma factor XI deficiency |
| RS376630432 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS376630473 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376630579 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS376631391 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrest, Brugada syndrome 8 |
| RS376631476 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS3766317 |
STIL
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 7, primary |
| RS376632173 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Inborn genetic diseases |
| RS376632263 |
DKC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS376632574 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS376632767 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS376632839 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS376633284 |
STAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS376633374 |
FSCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 30, Leber congenital amaurosis |
| RS376633424 |
WDR62
|
Health Risk |
Pathogenic |
— |
| RS376634193 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS376634713 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS376635152 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS376635652 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS376636291 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, LOXHD1-related disorder |
| RS376636502 |
MARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency, Charcot-Marie-Tooth disease axonal type 2U |
| RS376636910 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376636949 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS3766379 |
CD244
|
Health Risk |
risk factor |
Rheumatoid arthritis, Rheumatoid arthritis |
| RS376638283 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS376638940 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ZNF469-related disorder |
| RS376639281 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS376639978 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS376640377 |
WNT5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376640553 |
KCNJ5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperaldosteronism type III, Familial hyperaldosteronism type III |
| RS376641196 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS376641216 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, Inborn genetic diseases |
| RS376641234 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS376641474 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376641868 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS376642208 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS376643015 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS376643618 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS376644135 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculotrichoanal syndrome, BNAR syndrome |
| RS376644553 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS376644970 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS376645523 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS376645617 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS376647978 |
DDC
|
Health Risk |
Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS376648777 |
DOCK6
|
Health Risk |
Pathogenic |
— |
| RS376649198 |
TNK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376649412 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS376649488 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2A (Zellweger), Peroxisome biogenesis disorder 2B |
| RS376651004 |
DTNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 1, Left ventricular noncompaction 1 |
| RS376651419 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS376651641 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS376651720 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS376653237 |
DNAJC21
|
Health Risk |
Likely pathogenic |
— |
| RS376653349 |
SLC26A4
|
Health Risk |
Pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS376653399 |
DNAH1
|
Health Risk |
Likely pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS376653409 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypobetalipoproteinemia, Hypercholesterolemia |
| RS376653815 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS376654190 |
PGAM4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376654625 |
RPL3L
|
Health Risk |
Pathogenic |
Cardiomyopathy, dilated |
| RS376655102 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS376656512 |
JMJD1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Early myoclonic encephalopathy, Early myoclonic encephalopathy |
| RS376656751 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS376658420 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS376658460 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS376659221 |
SGCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS376659273 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 7, Nephronophthisis 8 |
| RS376659281 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, VPS13B-related disorder |
| RS376659578 |
COG8
|
Health Risk |
Conflicting classifications of pathogenicity |
COG8-congenital disorder of glycosylation, COG8-congenital disorder of glycosylation |
| RS376661693 |
ACAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS376662045 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS376663459 |
COG4
|
Health Risk |
Pathogenic/Likely pathogenic |
COG4-congenital disorder of glycosylation, COG4-Related Disorders |
| RS376663560 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, progressive familial intrahepatic |
| RS376663785 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, GM1 gangliosidosis type 3 |
| RS376663839 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS376664046 |
FLG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376664058 |
COL9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376664167 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS376664318 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS376665590 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376665722 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS376665854 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex |
| RS376666221 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS376667075 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS376667778 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS376668219 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS376669368 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS376670171 |
MC1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Melanoma |
| RS376670657 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS376671385 |
ATP6V1B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS376672264 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |